Clinical trials recruiting for EGFR Exon 20 Insertion Mutation
3
Recruiting trials
0
US states with sites
2
Countries
0%
Accept healthy volunteers
Phase breakdown
Phase 2 2Not applicable 1
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| BEBT-109 Capsule | 1 |
| Furmonertinib | 1 |
Self-screener
Recruiting trials
- Observational Multicenter Study in Patients Receiving Chemotherapy and Amivantamab for Metastatic Non-small Cell Lung Cancer
- Study of BEBT-109 in Subjects With EGFR Exon 20 Insertion Mutations Non-Small Cell Lung Cancer
- To Assess the Efficacy and Safety of Furmonertinib in Patients With Epidermal Growth Factor Receptor 20ins Mutation Positive Stage IB-IIIA Non-small Cell Lung Carcinoma, Following Complete Tumour Resection With or Without Adjuvant Chemotherapy
Related conditions
Trials recruiting for EGFR Exon 20 Insertion Mutation often also study these conditions. Each links to its own recruiting-trial list.
Non-small cell lung cancer 507Lung cancer 2180Non Small Cell Lung Carcinoma 10Non Small Cell Lung Cancer Metastatic 16EGFR 6
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for EGFR Exon 20 Insertion Mutation trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.